Bradford A. Woodworth, MD

Slides:



Advertisements
Similar presentations
Comparison of the Biological Effects of Sudbury Particulate Matter (SPaM) with Other Particulate Types: Acute and Chronic Studies Sarah M. White Stacey.
Advertisements

SP-B Detection and Gene Expression in Chronic Rhinosinusitis Bradford A. Woodworth, MD Noam A. Cohen, MD, PhD Rachel Wood, BS Geeta Bhargave, BS John E.
Cystic Fibrosis: Using ferrets as a Disease Model.
Aims To examine branching morphogenesis and translumenal potential difference following pharmacological abrogation of chloride secretion. ; To examine.
METHODS Introduction Conclusions  The novel potentiator GP-2 is highly efficacious towards enhancing CFTR function following translational RT of PTCs,
CYSTIC FIBROSIS AND CELL COMMUNICATION. CFTR Cystic Fibrosis Transmembrane Conductance Regulator ( Or CFTR)  Is a transport protein for Chloride across.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Date of download: 6/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of Cystic Fibrosis Transmembrane Conductance.
Inhibition Of KCa3.1 Channel Is a Potential Novel Therapy for ADPKD
Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells  Takahisa Fujikawa, Seh-Hoon.
Correcting Airway dehydration in Cystic Fibrosis BRETT ROLLINS
Christina K. Marko, Balaraj B. Menon, Gang Chen, Jeffrey A
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Mouse Strain Modulates the Role of the Ciliated Cell in Acute Tracheobronchial Airway Injury-Distal Airways  Gregory W. Lawson, Laura S. Van Winkle, Elina.
Eotaxin: a Potential Target for Therapy in Chronic Rhinosinusitis
Bioelectric effects of quinine on polarized airway epithelial cells
Rong Hu, Ph. D. , Fei-miao Wang, M. D. , Liang Yu, Ph. D. , Yan Luo, M
Abnormally up-regulated cystic fibrosis transmembrane conductance regulator expression and uterine fluid accumulation contribute to Chlamydia trachomatis-induced.
Volume 2, Issue 3, Pages (September 1998)
Deleterious impact of hyperglycemia on cystic fibrosis airway ion transport and epithelial repair  Claudia Bilodeau, Olivier Bardou, Émilie Maillé, Yves.
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel  Emanuela Pesce, Giulia Gorrieri,
Base Treatment Corrects Defects Due to Misfolding of Mutant Cystic Fibrosis Transmembrane Conductance Regulator  Wan Namkung, Kyung Hwan Kim, Min Goo.
Volume 143, Issue 6, Pages (December 2010)
Bioelectric effects of quinine on polarized airway epithelial cells
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection  Hannah K. Bayes, Neil D. Ritchie, Christopher Ward,
Loyola Marymount University
Volume 13, Issue 6, Pages (November 2015)
Volume 142, Issue 2, Pages (February 2012)
Ashley L Cooney, Brajesh K Singh, Patrick L Sinn  Molecular Therapy 
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
by Kelly A. McGowan, Wendy W. Pang, Rashmi Bhardwaj, Marcelina G
Ambra Gianotti, Valeria Capurro, Paolo Scudieri, Luis J. V
What is Biomedical Research?
What is Biomedical Research?
Journal of Cystic Fibrosis
Journal of Cystic Fibrosis
The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF  Paul D.W. Eckford, Jacqueline.
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation  Venkateshwar Mutyam,
Volume 137, Issue 3, Pages (September 2009)
Volume 85, Issue 5, Pages (May 2014)
Histamine Contributes to Tissue Remodeling via Periostin Expression
Volume 24, Issue 13, Pages e5 (September 2018)
Targeting ion channels in cystic fibrosis
Assessment of CFTR function in homozygous R117H-7T subjects
Volume 4, Issue 4, Pages (April 2015)
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking  Graeme W. Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes,
The CF Salt Controversy
Volume 123, Issue 6, Pages (December 2005)
Maturation, Ag presentation capacity, and IL-12 production of DCs
Volume 126, Issue 3, Pages (March 2004)
TRPV3 Channels Mediate Strontium-Induced Mouse-Egg Activation
A predominantly articular cartilage-associated gene, SCRG1, is induced by glucocorticoid and stimulates chondrogenesis in vitro  Kensuke Ochi, M.D., Ph.D.,
Shaoyan Zhang, Neel K. Ranganath, Daniel Skinner, David M
Volume 4, Issue 1, Pages (January 2015)
Volume 80, Issue 10, Pages (November 2011)
Karl Kunzelmann, Rainer Schreiber, Anissa Boucherot 
Volume 133, Issue 6, Pages e3 (December 2007)
Volume 11, Issue 6, Pages (June 2010)
Molecular Therapy - Methods & Clinical Development
Volume 6, Issue 3, Pages (March 2010)
Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells  Mustapha Si-Tahar, Didier Merlin,
Volume 18, Issue 2, Pages (February 2011)
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Volume 13, Issue 6, Pages (November 2015)
Loyola Marymount University
Volume 4, Issue 1, Pages (January 2015)
Volume 10, Issue 6, Pages (December 2004)
Ivacaftor restores G551D-cystic fibrosis transmembrane conductance regulator (CFTR) function in human bronchial epithelial (HBE) primary cell cultures.
Presentation transcript:

Bradford A. Woodworth, MD Characterization of Primary Rat Nasal Epithelial Cultures in CFTR-/- Rats as a Model for CF Sinus Disease Kiranya E. Tipirneni, MD Do-Yeon Cho, MD Daniel F. Skinner, BS Shaoyan Zhang, PhD Calvin Mackey, BS Dong-Jin Lim, PhD Bradford A. Woodworth, MD Good afternoon, I’m Kiranya Tipirneni, a post-doctoral research fellow at the University of Alabama at Birmingham. I want to thank the Triologic Society for allowing me to here and present this research with you all today.

Disclosures Bradford A. Woodworth, M.D. Consultant for Olympus, Cook Medical, Smith and Nephew Grant support from Cook Medical National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (1 R01 HL133006-01) to B.A.W. National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK072482-04, CF Research Center Pilot Award) to B.A.W. National Cancer Institute (T32CA091078) to K.E.T. This research was funded through the NIH by the National Heart, Lung, and Blood Institute and the NIDDK.

Background Cystic fibrosis (CF) is the most common lethal genetic disease among Caucasians The majority of patients develop CRS Animal studies have been paramount in contributing to our understanding of CF Pharmaceutical testing Gene modification studies First, I’ll begin with a very brief background about cystic fibrosis. CF is the most common lethal genetic disease among Caucasians, with the majority of patients developing CRS. Currently, animal studies have been paramount in contributing to our understanding of the disease, particularly in regards to: Pharmaceutical testing Gene modification studies, and in vivo replication of CF pathogenesis So, as you can imagine, development of a suitable CF animal model continues to be of significant interest

Current CF Animal Models Currently, a number of CF animal models exist. These include the: CF mouse, Pig, Ferret, and, more recently, The CF rat.

Advantages to CF Rat Model Larger size (relative to mice) allows for: - Evaluation of multiple organs Surgical procedures Brief gestational period (21-23 days) & rapid maturation (8 weeks) Rats are traditional animal model for pharmacology/toxicology studies Cost Several advantages to CF rat model: Relative to mice, rats are significantly larger; thus, permitting sampling of larger tissue samples and surgical interventions not possible in smaller rodents Unlike pig and ferret models, rats have a brief gestational period followed by swift sexual maturation, which facilitates rapid colony propagation, breeding and longitudinal studies Furthermore, rats are also widely used for pharmacology and toxicity studies due to favorable pharmacokinetic and biodistribution profiles And lastly, they are significantly less costly in comparison to ferrets and pigs

Rat Nasal Septal Epithelium (RNSE) Primary RNSE cells cultured at an air-liquid interface on semipermeable supports Scanning electron microscopy (SEM) Histology Ion transport studies RT-PCR In this study, we aimed to develop primary RNSE cultures and evaluate their utility as a model for investigating sinonasal transepithelial transport and CFTR function. Nasal septa of wild type and knockout rats were collected and cultured on semipermeable supports at an ALI. We evaluated RNSE cultured monolayers using SEM, histology, Ussing chamber analysis for pharmacologic manipulation and measurement of ion transport, and RT-PCR to evaluate relative CFTR gene expression.

Species Comparison with Mouse and Human NSE Primary MNSE and HNSE cells cultured at an air-liquid interface on semipermeable supports Ion transport studies RT-PCR Additionally, sinonasal epithelia from mice and humans were cultured at an ALI for comparing ion transport and gene expression between the different species.

Ciliary differentiation visualized with SEM CFTR+/+ 5x 25x CFTR-/- By day 14, cultured monolayers demonstrated complete differentiation We identified robust ciliary beating with 80 to 90% ciliation throughout the apical monolayer surface, shown here at low and high magnification. 5x 25x

CF sinus epithelia have increased submucosal glands Intraepithelial Mucus/ Basement Membrane CFTR+/+ 6.1 ± 0.5 µm2/ mm CFTR-/- 8.7± 0.9 µm2/ mm CFTR+/+ CFTR-/- We then examined rat maxillary sinonasal epithelia for submucosal gland density with Alcian blue-periodic acid Schiff staining While we found no evidence of infection, we did find that KO rats demonstrated an increased number of submucosal glands with an average of 9 per mm basement membrane vs 6 glands in the WT model Glands shown in black arrows.

RNSE ISC measurements indicate CFTR-/- rats exhibit a robust bioelectric phenotype * * * Next, we performed ion transport studies of WT and KO rats after pharmacologic manipulation with: Amiloride—an epithelial Na+ channel inhibitor (ENaC) Forskolin—CFTR activator that acts via cAMP-dependent pathway INH-172—highly specific inhibitor of CFTR that blocks CFTR-dependent chloride channel; and UTP—stimulator of Ca-activated Cl- channels (i.e. TMEM16A) On the right, we have Ussing chamber short circuit current tracings where positive deflection represents anion moving from serosal to mucosal direction On the left, which summarizes our short circuit current measurements, you can clearly see WT rats exhibit a significantly more robust forskolin response and is consistent with the presence of CFTR On the other hand, KO rats demonstrate a significantly increased caclium-activated Cl- secretion with UTP-stimulated current which suggests that alternative calcium-activated Cl- pathways are abundant and possibly serve to ameliorate Cl- ion imbalance in CFTR deficient states. Which possibly can be account for lack of sinus disease in these models *p<0.05

RNSE have increased ion transport phenotype compared to MNSE and HNSE * * CFTR+/+ * * * *p<0.05 * * CFTR-/- For comparison, we performed similar pharmacologic manipulation and ion transport studies using mouse and human NSE cultures. Overall, we found that both WT and KO RNSE exhibit a more robust ion transport phenotype as compared to that observed in mice and humans. Use mouse cursor to point to WT current tracing

RNSE have similar CFTR expression as compared to MNSE and HNSE Lastly, we performed RT-PCR to evaluate relative amounts of CFTR expression in WT cultures derived from rats, mice, and humans. Our results indicate that there is comparable CFTR expression among these species Thus, indicating that the more robust ion transport phenotype exhibited by rats is not simply due to increased expression of CFTR channels

Summary of Rat Upper Airway CF rat sinonasal epithelia have increased submucosal glands KO rats exhibit robust bioelectric CF phenotype as indicated by ISC measurements of NSE UTP-stimulated ISC measurements in KO rats suggest presence of abundant alternative Cl- pathways RNSE have a more robust ion transport phenotype than that seen in mice or humans So, in summary: CF rat sinonasal epithelia demonstrate increased number of submucosal glands but no histological evidence of infection Short circuit current measurements of KO RNSE cultures reflect a robust bioelectric CF phenotype The robust UTP-stimulated current seen in KO rats suggests the presence of abundant alternative Cl- transport pathways, which may be responsible for lack of sinus disease observed in these models In comparison to mice and humans, RNSE exhibit increased ion transport phenotype in all pharmacologic manipulation studies (except UTP in WT)

Conclusions Provides a means for examining in vitro pharmacologic manipulation Useful resource for longitudinal studies (intrauterine through adulthood) for: Sinus development Electrophysiology Other endpoints relevant to disease mechanism So what do all these findings mean? In conclusion, RNSE cultures represent a good model for in vitro pharmacologic manipulation studies. In fact, the robust ion transport phenotype of RNSE cultures suggest rats are more responsive and susceptible to ion transport modulators and may represent a better model for in vitro ion transport studies when compared to mice. Lastly, they may be useful for longitudinal studies of sinus development, electrophysiology, and other pathophysiologic processes of CF.

Acknowledgements University of Alabama at Birmingham Woodworth Lab Bradford A. Woodworth, MD Do-Yeon Cho, MD Daniel F. Skinner, BS Shaoyan Zhang, PhD Calvin Mackey Dong-Jin Lim, PhD UAB Animal Models Core Facility Gregory Fleming James CF Research Center Thank you to the Triological Society for allowing me to be here and special thanks to Dr. Woodworth and everyone in Woodworth lab giving me the opportunity to present this data on their behalf. I will now take any questions.